Rules-Based Medicine a Q Squared Solutions Company

About:

Rules-Based Medicine is a multiplexed immunoassay testing laboratory that provides comprehensive protein biomarker services.

Website: http://rbm.q2labsolutions.com

Twitter/X: RBMQ2Solutions

Top Investors: Cross Creek, Stephens Group, Equity Group Investments

Description:

Rules-Based Medicine, a Q squared solutions company (RBM), the world's leading multiplexed biomarker testing laboratory, provides comprehensive protein biomarker products and services based on its Multi-Analyte Profiling (MAP) technology platform. RBM's biomarker testing service provides pre-clinical and clinical researchers with reproducible, quantitative, multiplexed immunoassay data for hundreds of proteins in a cost-effective manner, from a small sample volume and from multiple species. Their biomarker testing laboratory is CLIA certified and supports GLP studies.

Total Funding Amount:

$25M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Austin, Texas, United States

Founded Date:

2002-01-01

Contact Email:

rbm_info(AT)q2labsolutions.com

Founders:

Number of Employees:

51-100

Last Funding Date:

2007-10-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai